Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $598.36 Average Target Price from Brokerages

25 Apr 2026, 03:09 by Renee Jackson · The Cerbat Gem

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-six analysts that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eighteen have given a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $581.9130.

A number of research firms have issued reports on ISRG. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a report on Wednesday, March 11th. Sanford C. Bernstein lifted their price objective on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. BTIG Research reaffirmed a “buy” rating and set a $574.00 price objective on shares of Intuitive Surgical in a report on Wednesday. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th.

Check Out Our Latest Stock Analysis on Intuitive Surgical

Intuitive Surgical Trading Up 0.7%

Shares of ISRG stock opened at $482.22 on Wednesday. The firm has a market capitalization of $170.78 billion, a PE ratio of 58.45, a price-to-earnings-growth ratio of 4.09 and a beta of 1.68. The firm has a fifty day simple moving average of $477.47 and a two-hundred day simple moving average of $515.38. Intuitive Surgical has a 12 month low of $427.84 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.81 EPS. On average, equities analysts predict that Intuitive Surgical will post 8.2 earnings per share for the current fiscal year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Q1 beat and accelerating growth — ISRG reported a better-than-expected Q1 (EPS $2.50 vs. $2.08 consensus) with ~23% revenue growth and commentary pointing to rising procedures and an improved outlook, which underpins the stock’s upside today. Intuitive Surgical Beats Q1 — TipRanks
Positive Sentiment: Innovation and pricing power — Coverage notes revenue is outpacing procedures as the da Vinci 5 platform drives higher ASPs and service/consumable mix, supporting margin and longer-term upside. Innovation-Led Growth — Zacks
Positive Sentiment: Analyst support — Several sell‑side actions are favorable: Robert W. Baird raised its price target to $610 and BTIG reaffirmed a Buy; Goldman published a bullish outlook, adding conviction to the post‑earnings rally. Baird Raises PT — AmericanBankingNews BTIG Reaffirms Buy — AmericanBankingNews
Neutral Sentiment: Mixed analyst moves — Some firms trimmed targets (Jefferies to $515, Leerink and others adjusted targets), leaving consensus views varied; this increases volatility around near‑term price action. Jefferies Lowers PT — AmericanBankingNews
Neutral Sentiment: Short interest signal is uninformative — April data reported no meaningful short interest (0 shares reported), so short-squeeze risk appears minimal based on the published figures.
Neutral Sentiment: Contained cyber incident disclosed — Management reported a contained cyber event with remediation underway; investors will watch disclosures but the company says operations are not materially disrupted. Cybersecurity and Q1 Coverage — Yahoo
Negative Sentiment: Instrument recalls raise reliability questions — ISRG initiated multiple recalls of reusable da Vinci instruments after safety complaints (fraying/broken cables); recalls could pressure service/consumables revenue and hospital confidence if issues persist. Recalls and Revenue Risk — Yahoo
Negative Sentiment: Competition creeping in — Johnson & Johnson earned CE mark for a stapler that integrates with Ottava, signaling incremental competition in the surgical robotics ecosystem that investors should monitor. J&J CE Mark — MedTechDive

Insider Buying and Selling

In related news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The disclosure for this sale is available in the SEC filing. Insiders sold 32,943 shares of company stock worth $17,279,568 in the last ninety days. Corporate insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after purchasing an additional 263,828 shares during the last quarter. State Street Corp boosted its stake in Intuitive Surgical by 1.0% in the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after buying an additional 162,264 shares in the last quarter. Capital World Investors boosted its stake in Intuitive Surgical by 1.7% in the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after buying an additional 127,526 shares in the last quarter. Norges Bank purchased a new stake in Intuitive Surgical in the fourth quarter worth approximately $2,856,987,000. Finally, Invesco Ltd. boosted its stake in Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after buying an additional 611,268 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.